Safety of and Immune Response to a DNA HIV Vaccine Boosted With a Modified Vaccinia HIV Vaccine and Protein HIV Vaccine in Healthy Adults

Clinical Trial ID NCT01418235

PubWeight™ 2.43‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01418235

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Controlling the HIV/AIDS epidemic: current status and global challenges. Front Immunol 2012 0.92
2 Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants. PLoS One 2016 0.76
3 HIV Envelope Trimer Specific Immune Response Is Influenced by Different Adjuvant Formulations and Heterologous Prime-Boost. PLoS One 2016 0.75
Next 100